KYLEI DULES: Open Payments
NPI 1770303083 · STURGIS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,507 in 132 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $266 · 2025 $2,507
Food & beverage: $2,507
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $282 |
| AstraZeneca Pharmaceuticals LP | 12 | $270 |
| Novo Nordisk Inc | 15 | $247 |
| Vanda Pharmaceuticals Inc. | 10 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $186 |
| PFIZER INC. | 12 | $183 |
| Axsome Therapeutics, Inc. | 6 | $167 |
| Corcept Therapeutics | 12 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $110 |
Products named: FANAPT, CAPLYTA, NURTEC ODT, Auvelity, AIRSUPRA, Korlym, VRAYLAR, Wegovy.
Industry payments across MI — which companies pay providers there.
